In 2013, in a European prospective analysis, authors evaluated the associations between self-reported DM, its duration, age at DM diagnosis, and insulin treatment with the risk of BTC and HCC, independent of obesity [21]. The gene discussed is INS; the disease is hepatocellular carcinoma.